What is medicine’s missing measurement?
The managing director of Excel Venture Management discusses current regulatory hurdles to introducing new drugs, why aspirin would never make it to market today, and the hidden costs …
Latest Posts
Juan Enriquez at TEDMED 2011 – Q and A
The managing director of Excel Venture Management discusses current regulatory hurdles to getting medical advances to market.
What’s a good second step?
Eythor Bender’s Ekso Bionics makes powered, wearable robots known as “exoskeletons” that boost human strength, endurance, and mobility. But can they help a paraplegic walk? Watch this incredible …
Eythor Bender at TEDMED 2011 – Q and A
The CEO of Ekso Bionics, and a paralyzed man he helped, take questions about human exoskeletons – “wearable robots” – how they help paraplegics walk, and what lies …
Where will the next medical breakthroughs come from?
In the search for new medical breakthroughs, the EVP and chief medical officer of Pfizer asks: What if we just stepped out of our comfort zone and tapped …
What if we couldn’t hear music?
A Johns Hopkins neurotology specialist explains why humans hear music differently than other sounds, and why technology to help the hearing impaired, while relatively advanced, is still catching …
Charles Limb at TEDMED 2011 – Q and A
A Johns Hopkins surgeon and specialist in neurotology answers questions as to why Cochlear implant wearers still struggle to hear music.
Catherine Mohr – Q&A at TEDMED 2011
The Intuitive Surgical research director answers questions about getting new robotic tech to market, and whether engineers, not just doctors, could someday perform surgery.
What’s the future of intervention?
What’s on the horizon for safer and more cost-effective robotic surgery? The Intuitive Surgical engineer briefs on novel treatments, but adds that advances in other areas may eliminate …
Robert J. Hariri – Q&A at TEDMED 2011
The CEO of Cellular Therapeutics talks about his novel research in using placenta-derived stem cells to treat Crohn’s disease, to repair damaged tissues, and to create “organoids” for …